Covid-19: Key drugs, steroids in short supply; input costs surge

Two anti-virals — Remdesivir and Favipiravir — and Tocilizumab injections being used in the Covid-19 treatment have witnessed massive shortages over the last few months.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2TbzWrb
via IFTTT